Prostaglandin E2 modulates Na+,K+-ATPase activity in rat hippocampus: implications for neurological diseases. 2009

Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, RS, Brasil.

Prostaglandin E(2) (PGE(2)) is quantitatively one of the major prostaglandins synthesized in mammalian brain, and there is evidence that it facilitates seizures and neuronal death. However, little is known about the molecular mechanisms involved in such excitatory effects. Na(+),K(+)-ATPase is a membrane protein which plays a key role in electrolyte homeostasis maintenance and, therefore, regulates neuronal excitability. In this study, we tested the hypothesis that PGE(2) decreases Na(+),K(+)-ATPase activity, in order to shed some light on the mechanisms underlying the excitatory action of PGE(2). Na(+),K(+)-ATPase activity was determined by assessing ouabain-sensitive ATP hydrolysis. We found that incubation of adult rat hippocampal slices with PGE(2) (0.1-10 microM) for 30 min decreased Na(+),K(+)-ATPase activity in a concentration-dependent manner. However, PGE(2) did not alter Na(+),K(+)-ATPase activity if added to hippocampal homogenates. The inhibitory effect of PGE(2) on Na(+),K(+)-ATPase activity was not related to a decrease in the total or plasma membrane immunocontent of the catalytic alpha subunit of Na(+),K(+)-ATPase. We found that the inhibitory effect of PGE(2) (1 microM) on Na(+),K(+)-ATPase activity was receptor-mediated, as incubation with selective antagonists for EP1 (SC-19220, 10 microM), EP3 (L-826266, 1 microM) or EP4 (L-161982, 1 microM) receptors prevented the PGE(2)-induced decrease of Na(+),K(+)-ATPase activity. On the other hand, incubation with the selective EP2 agonist (butaprost, 0.1-10 microM) increased enzyme activity per se in a concentration-dependent manner, but did not prevent the inhibitory effect of PGE(2). Incubation with a protein kinase A (PKA) inhibitor (H-89, 1 microM) and a protein kinase C (PKC) inhibitor (GF-109203X, 300 nM) also prevented PGE(2)-induced decrease of Na(+),K(+)-ATPase activity. Accordingly, PGE(2) increased phosphorylation of Ser943 at the alpha subunit, a critical residue for regulation of enzyme activity. Importantly, we also found that PGE(2) decreases Na(+),K(+)-ATPase activity in vivo. The results presented here imply Na(+),K(+)-ATPase as a target for PGE(2)-mediated signaling, which may underlie PGE(2)-induced increase of brain excitability.

UI MeSH Term Description Entries
D008297 Male Males
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000254 Sodium-Potassium-Exchanging ATPase An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. ATPase, Sodium, Potassium,Adenosinetriphosphatase, Sodium, Potassium,Na(+)-K(+)-Exchanging ATPase,Na(+)-K(+)-Transporting ATPase,Potassium Pump,Sodium Pump,Sodium, Potassium ATPase,Sodium, Potassium Adenosinetriphosphatase,Sodium-Potassium Pump,Adenosine Triphosphatase, Sodium, Potassium,Na(+) K(+)-Transporting ATPase,Sodium, Potassium Adenosine Triphosphatase,ATPase Sodium, Potassium,ATPase, Sodium-Potassium-Exchanging,Adenosinetriphosphatase Sodium, Potassium,Pump, Potassium,Pump, Sodium,Pump, Sodium-Potassium,Sodium Potassium Exchanging ATPase,Sodium Potassium Pump
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
September 1989, The American journal of physiology,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
December 2001, Neurochemical research,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
July 1994, The Journal of biological chemistry,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
September 2006, Neuroscience letters,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
February 1989, Neuroscience letters,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
April 1988, The Biochemical journal,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
March 2013, Synapse (New York, N.Y.),
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
August 2021, The Journal of physiology,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
May 2005, Molecular and cellular endocrinology,
Mauro Schneider Oliveira, and Ana Flávia Furian, and Leonardo Magno Rambo, and Leandro Rodrigo Ribeiro, and Luiz Fernando Freire Royes, and Juliano Ferreira, and João Batista Calixto, and Luis Fernando Pacheco Otalora, and Emilio Rafael Garrido-Sanabria, and Carlos Fernando Mello
January 2004, Physiology & behavior,
Copied contents to your clipboard!